The Cell and Gene Therapy Event for Ground-Breaking Manufacturing, Commercialization and Supply Chain Strategies

• Discover process optimization and implementation strategies for automated, closed, and integrated systems in autologous cell therapy manufacturing
• Gain industry insights on increasing process productivity and reducing cost of goods
• Uncover CDMO selection, tech transfer and external manufacturing best practices
• Build your analytical toolbox to improve testing, characterization & validation strategies
  
  

• Build a strategy for the scale up and robust manufacturing of next generation “off the shelf” allogeneic and gene edited modalities
• Get to grips with manufacturing and commercialization strategies for CAR-Ts, NK cells, TCRs, TILs and iPSCs products
• Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies
• New for 2023 – Discuss next generation non-viral vectors and their potential to transform the field

• Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
• Discuss improvement and innovations in cell line development and upstream processing to increase yields and process productivity
• Evaluate new technologies to overcome downstream processing and viral clearance challenges
• Develop analytical toolkits for AAV characterization, process comparability and understanding CQAs

• 1 full day dedicated to getting to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains
• Hear case study examples on improving vein to vein time and reliable distribution of CGT products
• Discover the application of digitalization to optimize chain of identity and custody traceability
• Explore best practises for preparing supply chain infrastructure for the future surge of cell and gene therapy products on the market

• Benefit from a conference pass including access to all talks and content across both events
• Maximize networking opportunities with attendees working in MAbs, vaccines & novel biological products
• Connect with leading technology innovators across all phases of biopharmaceutical production and development

• CDMO Partnerships
• Principles and Practices of CMC Analytics for Cell and Gene Therapy
• mRNA Process Development & Manufacturing
• Application of Exosomes
• Cell Line Development & Engineering
• Tech Transfer for Biopharmaceutical Manufacturing
• Data Management and Predictive Analytics

Gain practical advice from case studies, FDA & regulatory leaders to accelerate your biologics & novel modalities/molecules to market.